BRCA1 and BRCA2 germline mutations driven signaling pathway alterations are sufficient to initiate breast tumorigenesis by the PIK3CAH1047R oncogene. https://www.biorxiv.org/content/10.1101/2023.07.26.550741v1?med=mas
BRCA1 and BRCA2 germline mutations driven signaling pathway alterations are sufficient to initiate breast tumorigenesis by the PIK3CAH1047R oncogene. https://www.biorxiv.org/content/10.1101/2023.07.26.550741v1?med=mas